Início › Leucemia Mieloide Aguda › Kentucky › Louisville
Ensaios clínicos de Leucemia Mieloide Aguda em Louisville, KY
12 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Louisville e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecrutandoFase 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RecrutandoFase 3
- UofL Health Brown Cancer Center, Louisville
- Norton Cancer Institute, Louisville
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecrutandoFase 3
- Norton Children's Hospital, Louisville
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
RecrutandoFase 3
- Norton Children's Hospital, Louisville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecrutandoFase 1/2
- Norton Children's Hospital, Louisville
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RecrutandoFase 3
- Norton Children's Hospital, Louisville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- University of Louisville Hospital - James Brown Cancer Center, Louisville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecrutandoFase 1
- University of Kentucky Markey Cancer Center, Louisville
- Norton Cancer Institute - St. Matthews, Louisville
Ensaios de Leucemia Mieloide Aguda em outras cidades
- Houston, TX85 estudos
- New York City, NY51 estudos
- Boston, MA44 estudos
- Seattle, WA41 estudos
- Baldwin Park, CA40 estudos
- Columbus, OH35 estudos
- Philadelphia, PA34 estudos
- Durham, NC33 estudos
- Atlanta, GA31 estudos
- Tampa, FL29 estudos
- Chicago, IL26 estudos
- Portland, OR25 estudos
Outros estudos em Louisville
- Câncer de Pulmão de Não Pequenas Células22 estudos
- Obesidade17 estudos
- Sobrepeso15 estudos
- Câncer (todos os tipos)14 estudos
- Insuficiência Cardíaca13 estudos
- Mieloma Múltiplo12 estudos
- Câncer de Ovário12 estudos
- Câncer de Mama11 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço11 estudos
- Câncer de Pulmão11 estudos
- Melanoma10 estudos
- Câncer de Próstata10 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.